NCT06713993 Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
| NCT ID | NCT06713993 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Semmelweis University |
| Condition | Esophageal Cancer (EsC) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-09-10 |
| Primary Completion | 2029-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-09-10 with a primary completion date of 2029-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this observational study was to gain a deeper understanding of the epidemiology of the disease in Hungary through a broad analysis of patients with new-onset esophageal-oesophageal-stomach junction tumors, and to identify key parameters that could potentially influence the outcome of the disease and are closely correlated with morbidity and mortality. The investigators' primary objective is to identify potential factors and conditions that could be influenced and modified to enhance the disease outcome. Main questions: 1. What are the measurable changes in performance, workload, nutritional status, cardiac function, mental status in the patients studied? 2. What is the time course of the changes during and after treatment? 3. Which pathological parameters are associated with disease outcome and which are potential points of intervention to improve the course of the disease? Patients will undergo a detailed physical and nutritional assessment, non-invasive imaging tests and several questionnaires in addition to the usual pre- and post-operative examinations.
Eligibility Criteria
Inclusion Criteria: * Age over 18 years * Diagnosis of new-onset esophageal, esophagogastric junction tumor * Elective curative surgery (open/laparoscopic regardless of surgical technique) * Patients who have not yet received oncological treatment for their present disease Exclusion Criteria: * Lack of consent * Lack of cooperation * Contraindications for some studies: If MR scan is contraindicated, cardiac MR scan is not performed
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06713993 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Cancer (EsC). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06713993 currently recruiting?
Yes, NCT06713993 is actively recruiting participants. Contact the research team at vass.tamas@semmelweis.hu for enrollment information.
Where is the NCT06713993 trial being conducted?
This trial is being conducted at Budapest, Hungary.
Who is sponsoring the NCT06713993 clinical trial?
NCT06713993 is sponsored by Semmelweis University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.